v3.26.1
Segment Information - Research and development costs and an allocation of indirect research and development costs to each program (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
segment
Jun. 30, 2025
USD ($)
Segment Information        
Number of operating segments | segment     1  
Number of reportable segments | segment     1  
Total R&D Expense $ 67,542 $ 54,196 $ 140,543 $ 106,810
Single reportable segment        
Segment Information        
Total R&D Expense 67,542 54,196 140,543 106,810
Single reportable segment | Barzolvolimab/Anti-KIT Program        
Segment Information        
Total R&D Expense 54,946 42,645 117,110 82,348
Single reportable segment | CDX-622        
Segment Information        
Total R&D Expense 3,501 3,838 7,795 9,289
Single reportable segment | Other Programs        
Segment Information        
Total R&D Expense $ 9,095 $ 7,713 $ 15,638 $ 15,173